Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
8,120.00
-230.00 (-2.75%)
Jan 9, 2026, 3:30 PM KST
119.16% (1Y)
| Market Cap | 224.74B |
| Revenue (ttm) | 108.14B |
| Net Income (ttm) | 1.41B |
| Shares Out | 27.68M |
| EPS (ttm) | 60.34 |
| PE Ratio | 134.58 |
| Forward PE | n/a |
| Dividend | 30.00 (0.36%) |
| Ex-Dividend Date | Mar 4, 2025 |
| Volume | 1,158,784 |
| Average Volume | 5,712,088 |
| Open | 8,360.00 |
| Previous Close | 8,350.00 |
| Day's Range | 7,850.00 - 8,400.00 |
| 52-Week Range | 2,995.00 - 9,500.00 |
| Beta | 0.55 |
| RSI | 61.96 |
| Earnings Date | n/a |